Strategies for non-invasive delivery of biologics

References

• Adler M, Lee G. (1999). Stability and surface activity of lactate dehydrogenase in spray-dried trehalose. J Pharm Sci, 88, 199–208.
   PubMed Web of Science ®Google Scholar
• Adson A, Burton PS, Raub TJ, Barsuhn CL, Audus KL, Ho NF. (1995). Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers. J Pharm Sci, 84, 1197–1204.
   PubMed Web of Science ®Google Scholar
• Al-Qadi S, Grenha A, Carrión-Recio D, Seijo B, Remuñán-López C. (2012). Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations. J Control Release, 157, 383–390.
   PubMed Web of Science ®Google Scholar
• Alabraba V, Farnsworth A, Leigh R, Dodson P, Gough SC, Smyth T. (2009). Exubera inhaled insulin in patients with type 1 and type 2 diabetes: the first 12 months. Diabetes Technol Ther, 11, 427–430.
   PubMed Web of Science ®Google Scholar
• Amet N, Wang W, Shen WC. (2010). Human growth hormone-transferrin fusion protein for oral delivery in hypophysectomized rats. J Control Release, 141, 177–182.
   PubMed Web of Science ®Google Scholar
• Amidi M, Mastrobattista E, Jiskoot W, Hennink WE. (2010). Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev, 62, 59–82.
   PubMed Web of Science ®Google Scholar
• Ando T, Maitani Y, Yamamoto T, Takayama K, Nagai T. (1998). Nasal insulin delivery in rabbits using soybean-derived sterylglucoside and sterol mixtures as novel enhancers in suspension dosage forms. Biol Pharm Bull, 21, 862–865.
   PubMed Web of Science ®Google Scholar
• Andrews CW, Bennett L, Yu LX. (2000). Predicting human oral bioavailability of a compound: development of a novel quantitative structure-bioavailability relationship. Pharm Res, 17, 639–644.
   PubMed Web of Science ®Google Scholar
• Arnold MM, Gorman EM, Schieber LJ, Munson EJ, Berkland C. (2007). NanoCipro encapsulation in monodisperse large porous PLGA microparticles. J Control Release, 121, 100–109.
   PubMed Web of Science ®Google Scholar
• Aspden T, Illum L, Skaugrud O. (1997a). The effect of chronic nasal application of chitosan solutions on cilia beat frequency in guinea pigs. Int J Pharm, 153:137–146.
   Web of Science ®Google Scholar
• Aspden TJ, Mason JD, Jones NS, Lowe J, Skaugrud O, Illum L. (1997b). Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers. J Pharm Sci, 86, 509–513.
   PubMed Web of Science ®Google Scholar
• Aungst BJ. (2000). Intestinal permeation enhancers. J Pharm Sci, 89, 429–442.
   PubMed Web of Science ®Google Scholar
• Azarmi S, Roa WH, Löbenberg R. (2008). Targeted delivery of nanoparticles for the treatment of lung diseases. Adv Drug Deliv Rev, 60, 863–875.
   PubMed Web of Science ®Google Scholar
• Bai S, Ahsan F. (2009). Synthesis and evaluation of pegylated dendrimeric nanocarrier for pulmonary delivery of low molecular weight heparin. Pharm Res, 26, 539–548.
   PubMed Web of Science ®Google Scholar
• Bai S, Gupta V, Ahsan F. (2010). Inhalable lactose-based dry powder formulations of low molecular weight heparin. J Aerosol Med Pulm Drug Deliv, 23, 97–104.
   PubMed Web of Science ®Google Scholar
• Bai S, Thomas C, Ahsan F. (2007). Dendrimers as a carrier for pulmonary delivery of enoxaparin, a low-molecular weight heparin. J Pharm Sci, 96, 2090–2106.
   PubMed Web of Science ®Google Scholar
• Bailey MM, Gorman EM, Munson EJ, Berkland C. (2008). Pure insulin nanoparticle agglomerates for pulmonary delivery. Langmuir, 24, 13614–13620.
   PubMed Web of Science ®Google Scholar
• Balamurugan K, Ortiz A, Said HM. (2003). Biotin uptake by human intestinal and liver epithelial cells: role of the SMVT system. Am J Physiol Gastrointest Liver Physiol, 285, G73–G77.
   PubMed Web of Science ®Google Scholar
• Banerjee D, Flanagan PR, Cluett J, Valberg LS. (1986). Transferrin receptors in the human gastrointestinal tract. Relationship to body iron stores. Gastroenterology, 91, 861–869.
   PubMed Web of Science ®Google Scholar
• Banks WA. (2009). Characteristics of compounds that cross the blood-brain barrier. BMC Neurol, 9 Suppl 1, S3.
   PubMedGoogle Scholar
• Bernkop-Schnürch A. (2005). Thiomers: a new generation of mucoadhesive polymers. Adv Drug Deliv Rev, 57, 1569–1582.
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnürch A, Hornof M, Guggi D. (2004). Thiolated chitosans. Eur J Pharm Biopharm, 57, 9–17.
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnürch A, Kast CE. (2001). Chemically modified chitosans as enzyme inhibitors. Adv Drug Deliv Rev, 52, 127–137.
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnürch A, Kast CE, Guggi D. (2003). Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems. J Control Release, 93, 95–103.
   PubMed Web of Science ®Google Scholar
• Bi R, Shao W, Wang Q, Zhang N. (2008). Spray-freeze-dried dry powder inhalation of insulin-loaded liposomes for enhanced pulmonary delivery. J Drug Target, 16, 639–648.
   PubMed Web of Science ®Google Scholar
• Bi R, Shao W, Wang Q, Zhang N. (2009). Solid lipid nanoparticles as insulin inhalation carriers for enhanced pulmonary delivery. J Biomed Nanotechnol, 5, 84–92.
   PubMed Web of Science ®Google Scholar
• Bies C, Lehr CM, Woodley JF. (2004). Lectin-mediated drug targeting: history and applications. Adv Drug Deliv Rev, 56, 425–435.
   PubMed Web of Science ®Google Scholar
• Bilati U, Allémann E, Doelker E. (2005). Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. Eur J Pharm Biopharm, 59, 375–388.
   PubMed Web of Science ®Google Scholar
• Boonyo W, Junginger HE, Waranuch N, Polnok A, Pitaksuteepong T. (2007). Chitosan and trimethyl chitosan chloride (TMC) as adjuvants for inducing immune responses to ovalbumin in mice following nasal administration. J Control Release, 121, 168–175.
   PubMed Web of Science ®Google Scholar
• Bosquillon C, Lombry C, Préat V, Vanbever R. (2001). Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. J Control Release, 70, 329–339.
   PubMed Web of Science ®Google Scholar
• Bravo-Osuna I, Vauthier C, Farabollini A, Palmieri GF, Ponchel G. (2007). Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles. Biomaterials, 28, 2233–2243.
   PubMed Web of Science ®Google Scholar
• Brooks H, Lebleu B, Vivès E. (2005). Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev, 57, 559–577.
   PubMed Web of Science ®Google Scholar
• Cázares-Delgadillo J, Ganem-Rondero A, Kalia YN. (2011). Human growth hormone: new delivery systems, alternative routes of administration, and their pharmacological relevance. Eur J Pharm Biopharm, 78, 278–288.
   PubMed Web of Science ®Google Scholar
• Chae SY, Jang MK, Nah JW. (2005). Influence of molecular weight on oral absorption of water soluble chitosans. J Control Release, 102, 383–394.
   PubMed Web of Science ®Google Scholar
• Chae SY, Jin CH, Shin HJ, Youn YS, Lee S, Lee KC. (2008). Preparation, characterization, and application of biotinylated and biotin-PEGylated glucagon-like peptide-1 analogues for enhanced oral delivery. Bioconjug Chem, 19, 334–341.
   PubMed Web of Science ®Google Scholar
• Chalasani KB, Russell-Jones GJ, Jain AK, Diwan PV, Jain SK. (2007). Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles. J Control Release, 122, 141–150.
   PubMed Web of Science ®Google Scholar
• Chandy T, Sharma CP. (1993). Chitosan matrix for oral sustained delivery of ampicillin. Biomaterials, 14, 939–944.
   PubMed Web of Science ®Google Scholar
• Chatterjee NS, Kumar CK, Ortiz A, Rubin SA, Said HM. (1999). Molecular mechanism of the intestinal biotin transport process. Am J Physiol, 277, C605–C613.
   PubMed Web of Science ®Google Scholar
• Chen MC, Wong HS, Lin KJ, Chen HL, Wey SP, Sonaje K, Lin YH, Chu CY, Sung HW. (2009). The characteristics, biodistribution and bioavailability of a chitosan-based nanoparticulate system for the oral delivery of heparin. Biomaterials, 30, 6629–6637.
   PubMed Web of Science ®Google Scholar
• Cheng WP, Thompson C, Ryan SM, Aguirre T, Tetley L, Brayden DJ. (2010). In vitro and in vivo characterisation of a novel peptide delivery system: amphiphilic polyelectrolyte-salmon calcitonin nanocomplexes. J Control Release, 147, 289–297.
   PubMed Web of Science ®Google Scholar
• Chiang PC, Alsup JW, Lai Y, Hu Y, Heyde BR, Tung D. (2009). Evaluation of Aerosol Delivery of Nanosuspension for Pre-clinical Pulmonary Drug Delivery. Nanoscale Res Lett, 4, 254–261.
   PubMed Web of Science ®Google Scholar
• Chono S, Fukuchi R, Seki T, Morimoto K. (2009). Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary insulin delivery. J Control Release, 137, 104–109.
   PubMed Web of Science ®Google Scholar
• Chono S, Tanino T, Seki T, Morimoto K. (2006). Influence of particle size on drug delivery to rat alveolar macrophages following pulmonary administration of ciprofloxacin incorporated into liposomes. J Drug Target, 14, 557–566.
   PubMed Web of Science ®Google Scholar
• Chono S, Tanino T, Seki T, Morimoto K. (2007). Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification. J Pharm Pharmacol, 59, 75–80.
   PubMed Web of Science ®Google Scholar
• Codrons V, Vanderbist F, Ucakar B, Préat V, Vanbever R. (2004). Impact of formulation and methods of pulmonary delivery on absorption of parathyroid hormone (1-34) from rat lungs. J Pharm Sci, 93, 1241–1252.
   PubMed Web of Science ®Google Scholar
• Conacher M, Alexander J, Brewer JM. (2001). Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes). Vaccine, 19, 2965–2974.
   PubMed Web of Science ®Google Scholar
• Cone RA. (2009). Barrier properties of mucus. Adv Drug Deliv Rev, 61, 75–85.
   PubMed Web of Science ®Google Scholar
• Davis SS, Illum L. (2003). Absorption enhancers for nasal drug delivery. Clin Pharmacokinet, 42, 1107–1128.
   PubMed Web of Science ®Google Scholar
• Degim Z, Unal N, Essiz D, Abbasoglu U. (2004). The effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer. Life Sci, 75, 2819–2827.
   PubMed Web of Science ®Google Scholar
• Derossi D, Joliot AH, Chassaing G, Prochiantz A. (1994). The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem, 269, 10444–10450.
   PubMed Web of Science ®Google Scholar
• Dhuria SV, Hanson LR, Frey WH, 2nd. (2010). Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci, 99, 1654–1673.
   PubMed Web of Science ®Google Scholar
• Di Colo G, Burgalassi S, Zambito Y, Monti D, Chetoni P. (2004). Effects of different N-trimethyl chitosans on in vitro/in vivo ofloxacin transcorneal permeation. J Pharm Sci, 93, 2851–2862.
   PubMed Web of Science ®Google Scholar
• Di Colo G, Zambito Y, Zaino C. (2008). Polymeric enhancers of mucosal epithelia permeability: synthesis, transepithelial penetration-enhancing properties, mechanism of action, safety issues. J Pharm Sci, 97, 1652–1680.
   PubMed Web of Science ®Google Scholar
• Dressman JB, Thelen K, Jantratid E. (2008). Towards quantitative prediction of oral drug absorption. Clin Pharmacokinet, 47, 655–667.
   PubMed Web of Science ®Google Scholar
• du Plessis LH, Kotzé AF, Junginger HE. (2010a). Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride. Drug Deliv, 17, 399–407.
   PubMed Web of Science ®Google Scholar
• du Plessis LH, Lubbe J, Strauss T, Kotzé AF. (2010b). Enhancement of nasal and intestinal calcitonin delivery by the novel Pheroid fatty acid based delivery system, and by N-trimethyl chitosan chloride. Int J Pharm, 385, 181–186.
   PubMed Web of Science ®Google Scholar
• Dünnhaupt S, Barthelmes J, Hombach J, Sakloetsakun D, Arkhipova V, Bernkop-Schnürch A. (2011). Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa. Int J Pharm, 408, 191–199.
   PubMed Web of Science ®Google Scholar
• Edwards DA, Ben-Jebria A, Langer R. (1998). Recent advances in pulmonary drug delivery using large, porous inhaled particles. J Appl Physiol, 85, 379–385.
   PubMed Web of Science ®Google Scholar
• Edwards DA, Hanes J, Caponetti G, Hrkach J, Ben-Jebria A, Eskew ML, Mintzes J, Deaver D, Lotan N, Langer R. (1997). Large porous particles for pulmonary drug delivery. Science, 276, 1868–1871.
   PubMed Web of Science ®Google Scholar
• Eppstein DA, Longenecker JP. (1988). Alternative delivery systems for peptides and proteins as drugs. Crit Rev Ther Drug Carrier Syst, 5, 99–139.
   PubMed Web of Science ®Google Scholar
• Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ, Hardcastle JD. (1988). Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut, 29, 1035–1041.
   PubMed Web of Science ®Google Scholar
• Florea BI, Thanou M, Junginger HE, Borchard G. (2006). Enhancement of bronchial octreotide absorption by chitosan and N-trimethyl chitosan shows linear in vitro/in vivo correlation. J Control Release, 110, 353–361.
   PubMed Web of Science ®Google Scholar
• Föger F, Schmitz T, Bernkop-Schnürch A. (2006). In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan. Biomaterials, 27, 4250–4255.
   PubMed Web of Science ®Google Scholar
• Forbes B, Asgharian B, Dailey LA, Ferguson D, Gerde P, Gumbleton M, Gustavsson L, Hardy C, Hassall D, Jones R, Lock R, Maas J, McGovern T, Pitcairn GR, Somers G, Wolff RK. (2011). Challenges in inhaled product development and opportunities for open innovation. Adv Drug Deliv Rev, 63, 69–87.
   PubMed Web of Science ®Google Scholar
• Frokjaer S, Otzen DE. (2005). Protein drug stability: a formulation challenge. Nat Rev Drug Discov, 4, 298–306.
   PubMed Web of Science ®Google Scholar
• Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K, Sugiura Y. (2001). Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem, 276, 5836–5840.
   PubMed Web of Science ®Google Scholar
• Gabor F, Schwarzbauer A, Wirth M. (2002). Lectin-mediated drug delivery: binding and uptake of BSA-WGA conjugates using the Caco-2 model. Int J Pharm, 237, 227–239.
   PubMed Web of Science ®Google Scholar
• Gacesa P. (1988). Alginates. Carbohydrate Polymers, 8:161–182.
   Web of Science ®Google Scholar
• Gao Y, He L, Katsumi H, Sakane T, Fujita T, Yamamoto A. (2008). Improvement of intestinal absorption of water-soluble macromolecules by various polyamines: intestinal mucosal toxicity and absorption-enhancing mechanism of spermine. Int J Pharm, 354, 126–134.
   PubMed Web of Science ®Google Scholar
• Ge YC, Morgan RG. (1993). The effect of trypsin inhibitor on the pancreas and small intestine of mice. Br J Nutr, 70, 333–345.
   PubMed Web of Science ®Google Scholar
• George M, Abraham TE. (2006). Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan–a review. J Control Release, 114, 1–14.
   PubMed Web of Science ®Google Scholar
• Goldberg M, Gomez-Orellana I. (2003). Challenges for the oral delivery of macromolecules. Nat Rev Drug Discov, 2, 289–295.
   PubMed Web of Science ®Google Scholar
• Goto T, Morishita M, Kavimandan NJ, Takayama K, Peppas NA. (2006). Gastrointestinal transit and mucoadhesive characteristics of complexation hydrogels in rats. J Pharm Sci, 95, 462–469.
   PubMed Web of Science ®Google Scholar
• Greenwald RB, Choe YH, McGuire J, Conover CD. (2003). Effective drug delivery by PEGylated drug conjugates. Adv Drug Deliv Rev, 55, 217–250.
   PubMed Web of Science ®Google Scholar
• Grenha A, Seijo B, Remuñán-López C. (2005). Microencapsulated chitosan nanoparticles for lung protein delivery. Eur J Pharm Sci, 25, 427–437.
   PubMed Web of Science ®Google Scholar
• Hamman JH, Enslin GM, Kotzé AF. (2005). Oral delivery of peptide drugs: barriers and developments. BioDrugs, 19, 165–177.
   PubMed Web of Science ®Google Scholar
• Hamman JH, Stander M, Kotzé AF. (2002). Effect of the degree of quaternisation of N-trimethyl chitosan chloride on absorption enhancement: in vivo evaluation in rat nasal epithelia. Int J Pharm, 232, 235–242.
   PubMed Web of Science ®Google Scholar
• Huang YY, Wang CH. (2006). Pulmonary delivery of insulin by liposomal carriers. J Control Release, 113, 9–14.
   PubMed Web of Science ®Google Scholar
• Hussain A, Majumder QH, Ahsan F. (2006). Inhaled insulin is better absorbed when administered as a dry powder compared to solution in the presence or absence of alkylglycosides. Pharm Res, 23, 138–147.
   PubMed Web of Science ®Google Scholar
• Illum L. (1998). Chitosan and its use as a pharmaceutical excipient. Pharm Res, 15, 1326–1331.
   PubMed Web of Science ®Google Scholar
• Illum L. (2003). Nasal drug delivery–possibilities, problems and solutions. J Control Release, 87, 187–198.
   PubMed Web of Science ®Google Scholar
• Illum L. (2004). Is nose-to-brain transport of drugs in man a reality? J Pharm Pharmacol, 56, 3–17.
   PubMed Web of Science ®Google Scholar
• Illum L. (2007). Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems? J Pharm Sci, 96, 473–483.
   PubMed Web of Science ®Google Scholar
• Illum L, Farraj NF, Davis SS. (1994). Chitosan as a novel nasal delivery system for peptide drugs. Pharm Res, 11, 1186–1189.
   PubMed Web of Science ®Google Scholar
• Jain AK, Khar RK, Ahmed FJ, Diwan PV. (2008). Effective insulin delivery using starch nanoparticles as a potential trans-nasal mucoadhesive carrier. Eur J Pharm Biopharm, 69, 426–435.
   PubMed Web of Science ®Google Scholar
• Jalalipour M, Gilani K, Tajerzadeh H, Najafabadi AR, Barghi M. (2008a). Characterization and aerodynamic evaluation of spray dried recombinant human growth hormone using protein stabilizing agents. Int J Pharm, 352, 209–216.
   PubMed Web of Science ®Google Scholar
• Jalalipour M, Najafabadi AR, Gilani K, Esmaily H, Tajerzadeh H. (2008b). Effect of dimethyl-beta-cyclodextrin concentrations on the pulmonary delivery of recombinant human growth hormone dry powder in rats. J Pharm Sci, 97, 5176–5185.
   PubMed Web of Science ®Google Scholar
• Jensen DM, Cun D, Maltesen MJ, Frokjaer S, Nielsen HM, Foged C. (2010). Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation. J Control Release, 142, 138–145.
   PubMed Web of Science ®Google Scholar
• Jin Y, Song Y, Zhu X, Zhou D, Chen C, Zhang Z, Huang Y. (2012). Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport. Biomaterials, 33, 1573–1582.
   PubMed Web of Science ®Google Scholar
• Jintapattanakit A, Peungvicha P, Sailasuta A, Kissel T, Junyaprasert VB. (2010). Nasal absorption and local tissue reaction of insulin nanocomplexes of trimethyl chitosan derivatives in rats. J Pharm Pharmacol, 62, 583–591.
   PubMed Web of Science ®Google Scholar
• Johnson KA. (1997). Preparation of peptide and protein powders for inhalation. Adv Drug Deliv Rev, 26, 3–15.
   PubMed Web of Science ®Google Scholar
• Kamei N, Morishita M, Chiba H, Kavimandan NJ, Peppas NA, Takayama K. (2009a). Complexation hydrogels for intestinal delivery of interferon beta and calcitonin. J Control Release, 134, 98–102.
   PubMed Web of Science ®Google Scholar
• Kamei N, Morishita M, Eda Y, Ida N, Nishio R, Takayama K. (2008). Usefulness of cell-penetrating peptides to improve intestinal insulin absorption. J Control Release, 132, 21–25.
   PubMed Web of Science ®Google Scholar
• Kamei N, Morishita M, Takayama K. (2009b). Importance of intermolecular interaction on the improvement of intestinal therapeutic peptide/protein absorption using cell-penetrating peptides. J Control Release, 136, 179–186.
   PubMed Web of Science ®Google Scholar
• Kang SK, Woo JH, Kim MK, Woo SS, Choi JH, Lee HG, Lee NK, Choi YJ. (2008). Identification of a peptide sequence that improves transport of macromolecules across the intestinal mucosal barrier targeting goblet cells. J Biotechnol, 135, 210–216.
   PubMed Web of Science ®Google Scholar
• Kavimandan NJ, Losi E, Peppas NA. (2006). Novel delivery system based on complexation hydrogels as delivery vehicles for insulin-transferrin conjugates. Biomaterials, 27, 3846–3854.
   PubMed Web of Science ®Google Scholar
• Kean T, Thanou M. (2010). Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Deliv Rev, 62, 3–11.
   PubMed Web of Science ®Google Scholar
• Khafagy el-S, Morishita M, Isowa K, Imai J, Takayama K. (2009a). Effect of cell-penetrating peptides on the nasal absorption of insulin. J Control Release, 133, 103–108.
   PubMed Web of Science ®Google Scholar
• Khafagy el-S, Morishita M, Kamei N, Eda Y, Ikeno Y, Takayama K. (2009b). Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins. Int J Pharm, 381, 49–55.
   PubMed Web of Science ®Google Scholar
• Khafagy el-S, Morishita M, Onuki Y, Takayama K. (2007). Current challenges in non-invasive insulin delivery systems: a comparative review. Adv Drug Deliv Rev, 59, 1521–1546.
   PubMed Web of Science ®Google Scholar
• Khafagy el-S, Morishita M. (2012). Oral biodrug delivery using cell-penetrating peptide. Adv Drug Deliv Rev, 64, 531–539.
   PubMed Web of Science ®Google Scholar
• Khutoryanskiy VV. (2011). Advances in mucoadhesion and mucoadhesive polymers. Macromol Biosci, 11, 748–764.
   PubMed Web of Science ®Google Scholar
• Kim CY, Kim J, Han K, Kim S, Park K, Byun Y. (2007). Toxicity screening after repeated dose of a newly developed oral heparin derivative in male cynomolgus monkeys. J Toxicol Sci, 32, 411–420.
   PubMedGoogle Scholar
• Kim SK, Kim K, Lee S, Park K, Park JH, Kwon IC, Choi K, Kim CY, Byun Y. (2005). Evaluation of absorption of heparin-DOCA conjugates on the intestinal wall using a surface plasmon resonance. J Pharm Biomed Anal, 39, 861–870.
   PubMed Web of Science ®Google Scholar
• Kim SK, Lee DY, Kim CY, Nam JH, Moon HT, Byun Y. (2007a). A newly developed oral heparin derivative for deep vein thrombosis: non-human primate study. J Control Release, 123, 155–163.
   PubMed Web of Science ®Google Scholar
• Kim SK, Lee DY, Lee E, Lee YK, Kim CY, Moon HT, Byun Y. (2007b). Absorption study of deoxycholic acid-heparin conjugate as a new form of oral anti-coagulant. J Control Release, 120, 4–10.
   PubMed Web of Science ®Google Scholar
• Kleemann E, Neu M, Jekel N, Fink L, Schmehl T, Gessler T, Seeger W, Kissel T. (2005). Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI. J Control Release, 109, 299–316.
   PubMed Web of Science ®Google Scholar
• Kling J. (2008). Inhaled insulin's last gasp? Nat Biotechnol, Jun, p. 5.
   Web of Science ®Google Scholar
• Klingler C, Müller BW, Steckel H. (2009). Insulin-micro- and nanoparticles for pulmonary delivery. Int J Pharm, 377, 173–179.
   PubMed Web of Science ®Google Scholar
• Knowles MR, Boucher RC. (2002). Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest, 109, 571–577.
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Xu YJ, Samejima K, Goda H, Niitsu M, Takahashi M, Hashimoto Y. (2003). Fate of orally administered 15N-labeled polyamines in rats bearing solid tumors. Biol Pharm Bull, 26, 285–288.
   PubMed Web of Science ®Google Scholar
• Kobayashi S, Kondo S, Juni K. (1994). Study on pulmonary delivery of salmon calcitonin in rats: effects of protease inhibitors and absorption enhancers. Pharm Res, 11, 1239–1243.
   PubMed Web of Science ®Google Scholar
• Kobayashi S, Kondo S, Juni K. (1996). Pulmonary delivery of salmon calcitonin dry powders containing absorption enhancers in rats. Pharm Res, 13, 80–83.
   PubMed Web of Science ®Google Scholar
• Komada F, Iwakawa S, Yamamoto N, Sakakibara H, Okumura K. (1994). Intratracheal delivery of peptide and protein agents: absorption from solution and dry powder by rat lung. J Pharm Sci, 83, 863–867.
   PubMed Web of Science ®Google Scholar
• Kotzé AF, Thanou MM, Luebetaen HL, de Boer AG, Verhoef JC, Junginger HE. (1999). Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2). J Pharm Sci, 88, 253–257.
   PubMed Web of Science ®Google Scholar
• Koushik K, Dhanda DS, Cheruvu NP, Kompella UB. (2004). Pulmonary delivery of deslorelin: large-porous PLGA particles and HPbetaCD complexes. Pharm Res, 21, 1119–1126.
   PubMed Web of Science ®Google Scholar
• Koushik K, Kompella UB. (2004). Preparation of large porous deslorelin-PLGA microparticles with reduced residual solvent and cellular uptake using a supercritical carbon dioxide process. Pharm Res, 21, 524–535.
   PubMed Web of Science ®Google Scholar
• Krauland AH, Guggi D, Bernkop-Schnürch A. (2006). Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery. Int J Pharm, 307, 270–277.
   PubMed Web of Science ®Google Scholar
• Lai SK, Wang YY, Hanes J. (2009). Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev, 61, 158–171.
   PubMed Web of Science ®Google Scholar
• Lam JK, Liang W, Chan HK. (2012). Pulmonary delivery of therapeutic siRNA. Adv Drug Deliv Rev, 64, 1–15.
   PubMed Web of Science ®Google Scholar
• Leader B, Baca QJ, Golan DE. (2008). Protein therapeutics: a summary and pharmacological classification. Nat Rev Drug Discov, 7, 21–39.
   PubMed Web of Science ®Google Scholar
• Lee E, Kim H, Lee IH, Jon S. (2009). In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration. J Control Release, 140, 79–85.
   PubMed Web of Science ®Google Scholar
• Lee E, Lee J, Jon S. (2010). A novel approach to oral delivery of insulin by conjugating with low molecular weight chitosan. Bioconjug Chem, 21, 1720–1723.
   PubMed Web of Science ®Google Scholar
• Lee E, Lee J, Lee IH, Yu M, Kim H, Chae SY, Jon S. (2008). Conjugated chitosan as a novel platform for oral delivery of paclitaxel. J Med Chem, 51, 6442–6449.
   PubMed Web of Science ®Google Scholar
• Lee S, Youn YS, Lee SH, Byun Y, Lee KC. (2006a). PEGylated glucagon-like peptide-1 displays preserved effects on insulin release in isolated pancreatic islets and improved biological activity in db/db mice. Diabetologia, 49, 1608–1611.
   PubMed Web of Science ®Google Scholar
• Lee SH, Lee S, Youn YS, Na DH, Chae SY, Byun Y, Lee KC. (2005). Synthesis, characterization, and pharmacokinetic studies of PEGylated glucagon-like peptide-1. Bioconjug Chem, 16, 377–382.
   PubMed Web of Science ®Google Scholar
• Lee VHL, Yamamoto A. (1989). Penetration and enzymatic barriers to peptide and protein absorption. Adv Drug Deliv Rev, 4:171–207.
   Google Scholar
• Lee Y, Kim SH, Byun Y. (2000). Oral delivery of new heparin derivatives in rats. Pharm Res, 17, 1259–1264.
   PubMed Web of Science ®Google Scholar
• Lee YK, Kim SK, Lee DY, Lee S, Kim CY, Shin HC, Moon HT, Byun Y. (2006b). Efficacy of orally active chemical conjugate of low molecular weight heparin and deoxycholic acid in rats, mice and monkeys. J Control Release, 111, 290–298.
   PubMed Web of Science ®Google Scholar
• Lehr CM. (2000). Lectin-mediated drug delivery: the second generation of bioadhesives. J Control Release, 65, 19–29.
   PubMed Web of Science ®Google Scholar
• Lenzer J. (2006). Inhaled insulin is approved in Europe and United States. BMJ (Clinical research ed), Mar 11, p. 7537.
   Web of Science ®Google Scholar
• Lin CC, Metters AT. (2006). Hydrogels in controlled release formulations: network design and mathematical modeling. Adv Drug Deliv Rev, 58, 1379–1408.
   PubMed Web of Science ®Google Scholar
• Lin YH, Sonaje K, Lin KM, Juang JH, Mi FL, Yang HW, Sung HW. (2008). Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs. J Control Release, 132, 141–149.
   PubMed Web of Science ®Google Scholar
• Liu H, Tang R, Pan WS, Zhang Y, Liu H. (2003). Potential utility of various protease inhibitors for improving the intestinal absorption of insulin in rats. J Pharm Pharmacol, 55, 1523–1529.
   PubMed Web of Science ®Google Scholar
• Liu L, Fishman ML, Hicks KB, Kende M. (2005). Interaction of various pectin formulations with porcine colonic tissues. Biomaterials, 26, 5907–5916.
   PubMed Web of Science ®Google Scholar
• Liu P, Krishnan TR. (1999). Alginate-pectin-poly-L-lysine particulate as a potential controlled release formulation. J Pharm Pharmacol, 51, 141–149.
   PubMed Web of Science ®Google Scholar
• Lochhead JJ, Thorne RG. (2012). Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev, 64, 614–628.
   PubMed Web of Science ®Google Scholar
• Luessen HL, de Leeuw BJ, Langemeÿer MW, de Boer AB, Verhoef JC, Junginger HE. (1996). Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo. Pharm Res, 13, 1668–1672.
   PubMed Web of Science ®Google Scholar
• Maa YF, Nguyen PA, Hsu SW. (1998). Spray-drying of air-liquid interface sensitive recombinant human growth hormone. J Pharm Sci, 87, 152–159.
   PubMed Web of Science ®Google Scholar
• Maa YF, Nguyen PA, Sweeney T, Shire SJ, Hsu CC. (1999). Protein inhalation powders: spray drying vs spray freeze drying. Pharm Res, 16, 249–254.
   PubMed Web of Science ®Google Scholar
• Madsen F, Peppas NA. (1999). Complexation graft copolymer networks: swelling properties, calcium binding and proteolytic enzyme inhibition. Biomaterials, 20, 1701–1708.
   PubMed Web of Science ®Google Scholar
• Mahler GJ, Esch MB, Tako E, Southard TL, Archer SD, Glahn RP, Shuler ML. (2012). Oral exposure to polystyrene nanoparticles affects iron absorption. Nat Nanotechnol, 7, 264–271.
   PubMed Web of Science ®Google Scholar
• Makhlof A, Fujimoto S, Tozuka Y, Takeuchi H. (2011a). In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery. Eur J Pharm Biopharm, 77, 216–224.
   PubMed Web of Science ®Google Scholar
• Makhlof A, Tozuka Y, Takeuchi H. (2011b). Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Eur J Pharm Sci, 42, 445–451.
   PubMed Web of Science ®Google Scholar
• Makhlof A, Werle M, Tozuka Y, Takeuchi H. (2011c). A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa. J Control Release, 149, 81–88.
   PubMed Web of Science ®Google Scholar
• Marino MT, Costello D, Baughman R, Boss A, Cassidy J, Damico C, van Marle S, van Vliet A, Richardson PC. (2010). Pharmacokinetics and pharmacodynamics of inhaled GLP-1 (MKC253): proof-of-concept studies in healthy normal volunteers and in patients with type 2 diabetes. Clin Pharmacol Ther, 88, 243–250.
   PubMed Web of Science ®Google Scholar
• Marschütz MK, Caliceti P, Bernkop-Schnürch A. (2000). Design and in vivo evaluation of an oral delivery system for insulin. Pharm Res, 17, 1468–1474.
   PubMed Web of Science ®Google Scholar
• Marttin E, Verhoef JC, Romeijn SG, Merkus FW. (1995). Effects of absorption enhancers on rat nasal epithelium in vivo: release of marker compounds in the nasal cavity. Pharm Res, 12, 1151–1157.
   PubMed Web of Science ®Google Scholar
• Massodi I, Bidwell GL 3rd., Raucher D. (2005). Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery. J Control Release, 108, 396–408.
   PubMed Web of Science ®Google Scholar
• Mastrandrea LD, Quattrin T. (2006). Clinical evaluation of inhaled insulin. Adv Drug Deliv Rev, 58, 1061–1075.
   PubMed Web of Science ®Google Scholar
• Melmed RN, El-Aaser AA, Holt SJ. (1976). Hypertrophy and hyperplasia of the neonatal rat exocrine pancreas induced by orally administered soybean trypsin inhibitor. Biochim Biophys Acta, 421, 280–288.
   PubMed Web of Science ®Google Scholar
• Merkus FWHM, Schipper NGM, Hermens WAJJ, Romeijn SG, Verhoef JC. (1993). Absorption Enhancers in Nasal Drug Delivery - Efficacy and Safety. J Controlled Release, 24:201–208.
   Web of Science ®Google Scholar
• Mi FL, Wu YY, Lin YH, Sonaje K, Ho YC, Chen CT, Juang JH, Sung HW. (2008). Oral delivery of peptide drugs using nanoparticles self-assembled by poly(gamma-glutamic acid) and a chitosan derivative functionalized by trimethylation. Bioconjug Chem, 19, 1248–1255.
   PubMed Web of Science ®Google Scholar
• Minko T. (2004). Drug targeting to the colon with lectins and neoglycoconjugates. Adv Drug Deliv Rev, 56, 491–509.
   PubMed Web of Science ®Google Scholar
• Mitchell DJ, Kim DT, Steinman L, Fathman CG, Rothbard JB. (2000). Polyarginine enters cells more efficiently than other polycationic homopolymers. J Pept Res, 56, 318–325.
   PubMedGoogle Scholar
• Miyake M, Minami T, Hirota M, Toguchi H, Odomi M, Ogawara K, Higaki K, Kimura T. (2006a). Novel oral formulation safely improving intestinal absorption of poorly absorbable drugs: utilization of polyamines and bile acids. J Control Release, 111, 27–34.
   PubMed Web of Science ®Google Scholar
• Miyake M, Minami T, Toguchi H, Odomi M, Ogawara K, Higaki K, Kimura T. (2006b). Importance of bile acids for novel oral absorption system containing polyamines to improve intestinal absorption. J Control Release, 115, 130–133.
   PubMed Web of Science ®Google Scholar
• Morishita M, Goto T, Peppas NA, Joseph JI, Torjman MC, Munsick C, Nakamura K, Yamagata T, Takayama K, Lowman AM. (2004). Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption. J Control Release, 97, 115–124.
   PubMed Web of Science ®Google Scholar
• Morishita M, Kamei N, Ehara J, Isowa K, Takayama K. (2007). A novel approach using functional peptides for efficient intestinal absorption of insulin. J Control Release, 118, 177–184.
   PubMed Web of Science ®Google Scholar
• Morishita M, Lowman AM, Takayama K, Nagai T, Peppas NA. (2002). Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers. J Control Release, 81, 25–32.
   PubMed Web of Science ®Google Scholar
• Nakase I, Takeuchi T, Tanaka G, Futaki S. (2008). Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides. Adv Drug Deliv Rev, 60, 598–607.
   PubMed Web of Science ®Google Scholar
• Nemoto M, Hiki Y, Shimada K, Nakai N, Fujimoto K, Inoue S, Sakurada N, Kaneko H, Sugita M, Okabe M, Sasaki T. (2011). Novel hormonal delivery method using the ink-jet technology: application to pulmonary insulin therapies. Diabetes Technol Ther, 13, 509–517.
   PubMed Web of Science ®Google Scholar
• Niu M, Lu Y, Hovgaard L, Wu W. (2011). Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation. Int J Nanomedicine, 6, 1155–1166.
   PubMed Web of Science ®Google Scholar
• Niven RW, Lott FD, Ip AY, Cribbs JM. (1994). Pulmonary delivery of powders and solutions containing recombinant human granulocyte colony-stimulating factor (rhG-CSF) to the rabbit. Pharm Res, 11, 1101–1109.
   PubMed Web of Science ®Google Scholar
• Nojima Y, Suzuki Y, Iguchi K, Shiga T, Iwata A, Fujimoto T, Yoshida K, Shimizu H, Takeuchi T, Sato A. (2008). Development of poly(ethylene glycol) conjugated lactoferrin for oral administration. Bioconjug Chem, 19, 2253–2259.
   PubMed Web of Science ®Google Scholar
• Owens DR, Zinman B, Bolli G. (2003). Alternative routes of insulin delivery. Diabet Med, 20, 886–898.
   PubMed Web of Science ®Google Scholar
• Paliwal R, Paliwal SR, Agrawal GP, Vyas SP. (2012). Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation. Int J Pharm, 422, 179–184.
   PubMed Web of Science ®Google Scholar
• Park JW, Jeon OC, Kim SK, Al-Hilal TA, Jin SJ, Moon HT, Yang VC, Kim SY, Byun Y. (2010a). High antiangiogenic and low anticoagulant efficacy of orally active low molecular weight heparin derivatives. J Control Release, 148, 317–326.
   PubMed Web of Science ®Google Scholar
• Park JW, Jeon OC, Kim SK, Al-Hilal TA, Moon HT, Kim CY, Byun Y. (2010b). Anticoagulant efficacy of solid oral formulations containing a new heparin derivative. Mol Pharm, 7, 836–843.
   PubMed Web of Science ®Google Scholar
• Patton JS. (1996). Mechanisms of macromolecule absorption by the lungs. Adv Drug Deliv Rev, 19:3–36.
   Web of Science ®Google Scholar
• Patton JS, Byron PR. (2007). Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov, 6, 67–74.
   PubMed Web of Science ®Google Scholar
• Peppas NA, Khare AR. (1993). Preparation, Structure and Diffusional Behavior of Hydrogels in Controlled-Release. Adv Drug Deliv Rev, 11:1–35.
   Web of Science ®Google Scholar
• Pérez C, Griebenow K. (2003). Effect of salts on lysozyme stability at the water-oil interface and upon encapsulation in poly(lactic-co-glycolic) acid microspheres. Biotechnol Bioeng, 82, 825–832.
   PubMed Web of Science ®Google Scholar
• Petrus AK, Vortherms AR, Fairchild TJ, Doyle RP. (2007). Vitamin B12 as a carrier for the oral delivery of insulin. ChemMedChem, 2, 1717–1721.
   PubMed Web of Science ®Google Scholar
• Pinto-Alphandary H, Aboubakar M, Jaillard D, Couvreur P, Vauthier C. (2003). Visualization of insulin-loaded nanocapsules: in vitro and in vivo studies after oral administration to rats. Pharm Res, 20, 1071–1084.
   PubMed Web of Science ®Google Scholar
• Pistel KF, Kissel T. (2000). Effects of salt addition on the microencapsulation of proteins using W/O/W double emulsion technique. J Microencapsul, 17, 467–483.
   PubMed Web of Science ®Google Scholar
• Qian F, Mathias N, Moench P, Chi C, Desikan S, Hussain M, Smith RL. (2009). Pulmonary delivery of a GLP-1 receptor agonist, BMS-686117. Int J Pharm, 366, 218–220.
   PubMed Web of Science ®Google Scholar
• Ramanathan S, Pooyan S, Stein S, Prasad PD, Wang J, Leibowitz MJ, Ganapathy V, Sinko PJ. (2001). Targeting the sodium-dependent multivitamin transporter (SMVT) for improving the oral absorption properties of a retro-inverso Tat nonapeptide. Pharm Res, 18, 950–956.
   PubMed Web of Science ®Google Scholar
• Rawat A, Majumder QH, Ahsan F. (2008). Inhalable large porous microspheres of low molecular weight heparin: in vitro and in vivo evaluation. J Control Release, 128, 224–232.
   PubMed Web of Science ®Google Scholar
• Reese TS, Karnovsky MJ. (1967). Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol, 34, 207–217.
   PubMed Web of Science ®Google Scholar
• Rekha MR, Sharma CP. (2009). Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption. J Control Release, 135, 144–151.
   PubMed Web of Science ®Google Scholar
• Richardson DR. (2004). Mysteries of the transferrin-transferrin receptor 1 interaction uncovered. Cell, 116, 483–485.
   PubMed Web of Science ®Google Scholar
• Roberts MJ, Bentley MD, Harris JM. (2002). Chemistry for peptide and protein PEGylation. Adv Drug Deliv Rev, 54, 459–476.
   PubMed Web of Science ®Google Scholar
• Roger E, Lagarce F, Garcion E, Benoit JP. (2010). Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery. Nanomedicine (Lond), 5, 287–306.
   PubMed Web of Science ®Google Scholar
• Rosenstock J, Cefalu WT, Hollander PA, Klioze SS, Reis J, Duggan WT. (2009). Safety and efficacy of inhaled human insulin (exubera) during discontinuation and readministration of therapy in adults with type 2 diabetes: a 3-year randomized controlled trial. Diabetes Technol Ther, 11, 697–705.
   PubMed Web of Science ®Google Scholar
• Sadeghi AM, Avadi MR, Ejtemaimehr Sh, Abashzadeh Sh, Partoazar A, Dorkoosh F, Faghihi M, Rafiee-Tehrani M, Junginger HE. (2009). Development of a Gas Empowered Drug Delivery system for peptide delivery in the small intestine. J Control Release, 134, 11–17.
   PubMed Web of Science ®Google Scholar
• Sajeesh S, Bouchemal K, Marsaud V, Vauthier C, Sharma CP. (2010a). Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin. J Control Release, 147, 377–384.
   PubMed Web of Science ®Google Scholar
• Sajeesh S, Bouchemal K, Sharma CP, Vauthier C. (2010b). Surface-functionalized polymethacrylic acid based hydrogel microparticles for oral drug delivery. Eur J Pharm Biopharm, 74, 209–218.
   PubMed Web of Science ®Google Scholar
• Sajeesh S, Vauthier C, Gueutin C, Ponchel G, Sharma CP. (2010c). Thiol functionalized polymethacrylic acid-based hydrogel microparticles for oral insulin delivery. Acta Biomater, 6, 3072–3080.
   PubMed Web of Science ®Google Scholar
• Sakagami M. (2006). In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv Drug Deliv Rev, 58, 1030–1060.
   PubMed Web of Science ®Google Scholar
• Salama NN, Eddington ND, Fasano A. (2006). Tight junction modulation and its relationship to drug delivery. Adv Drug Deliv Rev, 58, 15–28.
   PubMed Web of Science ®Google Scholar
• Sanders N, Rudolph C, Braeckmans K, De Smedt SC, Demeester J. (2009). Extracellular barriers in respiratory gene therapy. Adv Drug Deliv Rev, 61, 115–127.
   PubMed Web of Science ®Google Scholar
• Sandri G, Bonferoni MC, Rossi S, Ferrari F, Gibin S, Zambito Y, Di Colo G, Caramella C. (2007). Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models. Eur J Pharm Biopharm, 65, 68–77.
   PubMed Web of Science ®Google Scholar
• Schilling RJ, Mitra AK. (1991). Degradation of insulin by trypsin and alpha-chymotrypsin. Pharm Res, 8, 721–727.
   PubMed Web of Science ®Google Scholar
• Schipper NGM, Verhoef J, Romeijn SG, Merkus, FWHM. (1992). Absorption Enhancers in Nasal Insulin Delivery and Their Influence on Nasal Ciliary Functioning. J Controlled Release, 21:173–185.
   Web of Science ®Google Scholar
• Schubert R, Jaroni H, Schoelmerich J, Schmidt KH. (1983). Studies on the mechanism of bile salt-induced liposomal membrane damage. Digestion, 28, 181–190.
   PubMed Web of Science ®Google Scholar
• Senel S, McClure SJ. (2004). Potential applications of chitosan in veterinary medicine. Adv Drug Deliv Rev, 56, 1467–1480.
   PubMed Web of Science ®Google Scholar
• Senior K. (2001). Bilosomes: the answer to oral vaccine delivery? Drug Discov Today, 6, 1031–1032.
   PubMed Web of Science ®Google Scholar
• Shao Z, Mitra AK. (1992). Nasal membrane and intracellular protein and enzyme release by bile salts and bile salt-fatty acid mixed micelles: correlation with facilitated drug transport. Pharm Res, 9, 1184–1189.
   PubMed Web of Science ®Google Scholar
• Shen WC. (2003). Oral peptide and protein delivery: unfulfilled promises? Drug Discov Today, 8, 607–608.
   PubMed Web of Science ®Google Scholar
• Shukla A, Katare OP, Singh B, Vyas SP. (2010). M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes. Int J Pharm, 385, 47–52.
   PubMed Web of Science ®Google Scholar
• Singh P, Prabakaran D, Jain S, Mishra V, Jaganathan KS, Vyas SP. (2004). Cholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunization. Int J Pharm, 278, 379–390.
   PubMed Web of Science ®Google Scholar
• Sintov AC, Levy HV, Botner S. (2010). Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies. J Control Release, 148, 168–176.
   PubMed Web of Science ®Google Scholar
• Smart JD. (2005). The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev, 57, 1556–1568.
   PubMed Web of Science ®Google Scholar
• Soane RJ, Frier M, Perkins AC, Jones NS, Davis SS, Illum L. (1999). Evaluation of the clearance characteristics of bioadhesive systems in humans. Int J Pharm, 178, 55–65.
   PubMed Web of Science ®Google Scholar
• Sonaje K, Chen YJ, Chen HL, Wey SP, Juang JH, Nguyen HN, Hsu CW, Lin KJ, Sung HW. (2010a). Enteric-coated capsules filled with freeze-dried chitosan/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery. Biomaterials, 31, 3384–3394.
   PubMed Web of Science ®Google Scholar
• Sonaje K, Lin KJ, Wey SP, Lin CK, Yeh TH, Nguyen HN, Hsu CW, Yen TC, Juang JH, Sung HW. (2010b). Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-responsive nanoparticles vs. subcutaneous injection. Biomaterials, 31, 6849–6858.
   PubMed Web of Science ®Google Scholar
• Sonaje K, Lin YH, Juang JH, Wey SP, Chen CT, Sung HW. (2009). In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials, 30, 2329–2339.
   PubMed Web of Science ®Google Scholar
• Song KH, Chung SJ, Shim CK. (2002). Preparation and evaluation of proliposomes containing salmon calcitonin. J Control Release, 84, 27–37.
   PubMed Web of Science ®Google Scholar
• Song KH, Chung SJ, Shim CK. (2005). Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts. J Control Release, 106, 298–308.
   PubMed Web of Science ®Google Scholar
• Staddon JM, Herrenknecht K, Smales C, Rubin LL. (1995). Evidence that tyrosine phosphorylation may increase tight junction permeability. J Cell Sci, 108 (Pt 2), 609–619.
   PubMedGoogle Scholar
• Steyn D, du Plessis L, Kotzé A. (2010). Nasal delivery of recombinant human growth hormone: in vivo evaluation with Pheroid technology and N-trimethyl chitosan chloride. J Pharm Pharm Sci, 13, 263–273.
   PubMed Web of Science ®Google Scholar
• Su FY, Lin KJ, Sonaje K, Wey SP, Yen TC, Ho YC, Panda N, Chuang EY, Maiti B, Sung HW. (2012). Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery. Biomaterials, 33, 2801–2811.
   PubMed Web of Science ®Google Scholar
• Sun S, Liang N, Kawashima Y, Xia D, Cui F. (2011). Hydrophobic ion pairing of an insulin-sodium deoxycholate complex for oral delivery of insulin. Int J Nanomedicine, 6, 3049–3056.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Machida M, Adachi K, Otabe K, Sugimoto T, Hayashi M, Awazu S. (2000). Histopathological study of the effects of a single intratracheal instillation of surface active agents on lung in rats. J Toxicol Sci, 25, 49–55.
   PubMedGoogle Scholar
• Sweeney LG, Wang Z, Loebenberg R, Wong JP, Lange CF, Finlay WH. (2005). Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery. Int J Pharm, 305, 180–185.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Matsui Y, Yamamoto H, Kawashima Y. (2003). Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. J Control Release, 86, 235–242.
   PubMed Web of Science ®Google Scholar
• Tavornvipas S, Tajiri S, Hirayama F, Arima H, Uekama K. (2004). Effects of hydrophilic cyclodextrins on aggregation of recombinant human growth hormone. Pharm Res, 21, 2369–2376.
   PubMed Web of Science ®Google Scholar
• Thanou M, Henderson S, Kydonieus A, Elson C. (2007). N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules. J Control Release, 117, 171–178.
   PubMed Web of Science ®Google Scholar
• Thanou M, Verhoef JC, Junginger HE. (2001a). Chitosan and its derivatives as intestinal absorption enhancers. Adv Drug Deliv Rev, 50 Suppl 1, S91–101.
   PubMed Web of Science ®Google Scholar
• Thanou M, Verhoef JC, Junginger HE. (2001b). Oral drug absorption enhancement by chitosan and its derivatives. Adv Drug Deliv Rev, 52, 117–126.
   PubMed Web of Science ®Google Scholar
• Thanou MM, Kotzé AF, Scharringhausen T, Luessen HL, de Boer AG, Verhoef JC, Junginger HE. (2000). Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal caco-2 cell monolayers. J Control Release, 64, 15–25.
   PubMed Web of Science ®Google Scholar
• Thirawong N, Nunthanid J, Puttipipatkhachorn S, Sriamornsak P. (2007). Mucoadhesive properties of various pectins on gastrointestinal mucosa: an in vitro evaluation using texture analyzer. Eur J Pharm Biopharm, 67, 132–140.
   PubMed Web of Science ®Google Scholar
• Thirawong N, Thongborisute J, Takeuchi H, Sriamornsak P. (2008). Improved intestinal absorption of calcitonin by mucoadhesive delivery of novel pectin-liposome nanocomplexes. J Control Release, 125, 236–245.
   PubMed Web of Science ®Google Scholar
• Thompson CJ, Tetley L, Uchegbu IF, Cheng WP. (2009). The complexation between novel comb shaped amphiphilic polyallylamine and insulin: towards oral insulin delivery. Int J Pharm, 376, 46–55.
   PubMedGoogle Scholar
• Thorne RG, Hanson LR, Ross TM, Tung D, Frey WH 2nd. (2008). Delivery of interferon-beta to the monkey nervous system following intranasal administration. Neuroscience, 152, 785–797.
   PubMed Web of Science ®Google Scholar
• Thorne RG, Pronk GJ, Padmanabhan V, Frey WH 2nd. (2004). Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience, 127, 481–496.
   PubMed Web of Science ®Google Scholar
• Tomoda K, Ohkoshi T, Nakajima T, Makino K. (2008). Preparation and properties of inhalable nanocomposite particles: effects of the size, weight ratio of the primary nanoparticles in nanocomposite particles and temperature at a spray-dryer inlet upon properties of nanocomposite particles. Colloids Surf B Biointerfaces, 64, 70–76.
   PubMed Web of Science ®Google Scholar
• Torchilin VP, Levchenko TS, Rammohan R, Volodina N, Papahadjopoulos-Sternberg B, D’Souza GG. (2003). Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc Natl Acad Sci USA, 100, 1972–1977.
   PubMed Web of Science ®Google Scholar
• Tuesca A, Nakamura K, Morishita M, Joseph J, Peppas N, Lowman A. (2008). Complexation hydrogels for oral insulin delivery: effects of polymer dosing on in vivo efficacy. J Pharm Sci, 97, 2607–2618.
   PubMed Web of Science ®Google Scholar
• Ungaro F, d’Emmanuele di Villa Bianca R, Giovino C, Miro A, Sorrentino R, Quaglia F, La Rotonda MI. (2009). Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. J Control Release, 135, 25–34.
   PubMed Web of Science ®Google Scholar
• Ungaro F, De Rosa G, Miro A, Quaglia F, La Rotonda MI. (2006). Cyclodextrins in the production of large porous particles: development of dry powders for the sustained release of insulin to the lungs. Eur J Pharm Sci, 28, 423–432.
   PubMed Web of Science ®Google Scholar
• van der Merwe SM, Verhoef JC, Verheijden JH, Kotzé AF, Junginger HE. (2004). Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. Eur J Pharm Biopharm, 58, 225–235.
   PubMed Web of Science ®Google Scholar
• van Drooge DJ, Hinrichs WL, Dickhoff BH, Elli MN, Visser MR, Zijlstra GS, Frijlink HW. (2005). Spray freeze drying to produce a stable Delta(9)-tetrahydrocannabinol containing inulin-based solid dispersion powder suitable for inhalation. Eur J Pharm Sci, 26, 231–240.
   PubMed Web of Science ®Google Scholar
• Veronese FM, Pasut G. (2005). PEGylation, successful approach to drug delivery. Drug Discov Today, 10, 1451–1458.
   PubMed Web of Science ®Google Scholar
• Vivès E, Brodin P, Lebleu B. (1997). A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem, 272, 16010–16017.
   PubMed Web of Science ®Google Scholar
• Wang X, Chi N, Tang X. (2008). Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. Eur J Pharm Biopharm, 70, 735–740.
   PubMed Web of Science ®Google Scholar
• Wang X, Zheng C, Wu Z, Teng D, Zhang X, Wang Z, Li C. (2009). Chitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin. J Biomed Mater Res Part B Appl Biomater, 88, 150–161.
   PubMed Web of Science ®Google Scholar
• Werle M, Takeuchi H. (2009). Chitosan-aprotinin coated liposomes for oral peptide delivery: Development, characterisation and in vivo evaluation. Int J Pharm, 370, 26–32.
   PubMed Web of Science ®Google Scholar
• Wheatley MA, Dent J, Wheeldon EB, Smith PL. (1988). Nasal Drug Delivery - an Invitro Characterization of Trans-Epithelial Electrical-Properties and Fluxes in the Presence or Absence of Enhancers. J Controlled Release, 8, 167–177.
   Web of Science ®Google Scholar
• Widera A, Kim KJ, Crandall ED, Shen WC. (2003). Transcytosis of GCSF-transferrin across rat alveolar epithelial cell monolayers. Pharm Res, 20, 1231–1238.
   PubMed Web of Science ®Google Scholar
• Woitiski CB, Carvalho RA, Ribeiro AJ, Neufeld RJ, Veiga F. (2008). Strategies toward the improved oral delivery of insulin nanoparticles via gastrointestinal uptake and translocation. BioDrugs, 22, 223–237.
   PubMed Web of Science ®Google Scholar
• Woitiski CB, Sarmento B, Carvalho RA, Neufeld RJ, Veiga F. (2011). Facilitated nanoscale delivery of insulin across intestinal membrane models. Int J Pharm, 412, 123–131.
   PubMed Web of Science ®Google Scholar
• Wood KM, Stone GM, Peppas NA. (2008). Wheat germ agglutinin functionalized complexation hydrogels for oral insulin delivery. Biomacromolecules, 9, 1293–1298.
   PubMed Web of Science ®Google Scholar
• Wood KM, Stone GM, Peppas NA. (2010). The effect of complexation hydrogels on insulin transport in intestinal epithelial cell models. Acta Biomater, 6, 48–56.
   PubMed Web of Science ®Google Scholar
• Woodley J. (2001). Bioadhesion: new possibilities for drug administration? Clin Pharmacokinet, 40, 77–84.
   PubMed Web of Science ®Google Scholar
• Woodley JF. (1994). Enzymatic barriers for GI peptide and protein delivery. Crit Rev Ther Drug Carrier Syst, 11, 61–95.
   PubMed Web of Science ®Google Scholar
• Wu ZM, Zhou L, Guo XD, Jiang W, Ling L, Qian Y, Luo KQ, Zhang LJ. (2012). HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin. Int J Pharm, 425, 1–8.
   PubMed Web of Science ®Google Scholar
• Xia CQ, Wang J, Shen WC. (2000). Hypoglycemic effect of insulin-transferrin conjugate in streptozotocin-induced diabetic rats. J Pharmacol Exp Ther, 295, 594–600.
   PubMed Web of Science ®Google Scholar
• Yamagata T, Morishita M, Kavimandan NJ, Nakamura K, Fukuoka Y, Takayama K, Peppas NA. (2006). Characterization of insulin protection properties of complexation hydrogels in gastric and intestinal enzyme fluids. J Control Release, 112, 343–349.
   PubMed Web of Science ®Google Scholar
• Yamamoto A, Taniguchi T, Rikyuu K, Tsuji T, Fujita T, Murakami M, Muranishi S. (1994). Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats. Pharm Res, 11, 1496–1500.
   PubMed Web of Science ®Google Scholar
• Yang J, Sun H, Song C. (2012). Preparation, characterization and in vivo evaluation of pH-sensitive oral insulin-loaded poly(lactic-co-glycolicacid) nanoparticles. Diabetes Obes Metab, 14, 358–364.
   PubMed Web of Science ®Google Scholar
• Yang T, Mustafa F, Bai S, Ahsan F. (2004). Pulmonary delivery of low molecular weight heparins. Pharm Res, 21, 2009–2016.
   PubMed Web of Science ®Google Scholar
• Yang W, Peters JI, Williams RO 3rd. (2008). Inhaled nanoparticles–a current review. Int J Pharm, 356, 239–247.
   PubMed Web of Science ®Google Scholar
• Yeo LY, Friend JR, McIntosh MP, Meeusen EN, Morton DA. (2010). Ultrasonic nebulization platforms for pulmonary drug delivery. Expert Opin Drug Deliv, 7, 663–679.
   PubMed Web of Science ®Google Scholar
• Yin L, Ding J, He C, Cui L, Tang C, Yin C. (2009). Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials, 30, 5691–5700.
   PubMed Web of Science ®Google Scholar
• Youn YS, Chae SY, Lee S, Jeon JE, Shin HG, Lee KC. (2007). Evaluation of therapeutic potentials of site-specific PEGylated glucagon-like peptide-1 isomers as a type 2 anti-diabetic treatment: Insulinotropic activity, glucose-stabilizing capability, and proteolytic stability. Biochem Pharmacol, 73, 84–93.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wu L, Chan HK, Watanabe W. (2011a). Formation, characterization, and fate of inhaled drug nanoparticles. Adv Drug Deliv Rev, 63, 441–455.
   PubMed Web of Science ®Google Scholar
• Zhang N, Ping QN, Huang GH, Xu WF. (2005a). Investigation of lectin-modified insulin liposomes as carriers for oral administration. Int J Pharm, 294, 247–259.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang H, Wu Z, Wang Z, Niu H, Li C. (2008). Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles. Eur J Pharm Biopharm, 68, 526–534.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wei W, Lv P, Wang L, Ma G. (2011b). Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin. Eur J Pharm Biopharm, 77, 11–19.
   PubMed Web of Science ®Google Scholar
• Zhang YJ, Ma CH, Lu WL, Zhang X, Wang XL, Sun JN, Zhang Q. (2005b). Permeation-enhancing effects of chitosan formulations on recombinant hirudin-2 by nasal delivery in vitro and in vivo. Acta Pharmacol Sin, 26, 1402–1408.
   PubMed Web of Science ®Google Scholar